Facilitated By

San Antonio Medical Foundation

News

  • TerSera® Presents New Real-World Evidence on Treatment Outcomes of Goserelin ...

    ... San Antonio, TX.1 A copy of the poster is available here ... Psyence Biomedical executes binding agreements with Optimi Health.

  • Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research ... - PR Newswire

    ... San Antonio Breast Cancer Symposium being held December 10-13, at the Henry B. Gonzalez Convention Center in San Antonio, Texas. The INVINCIBLE-4 ...

  • US appeals court rejects Nasdaq's diversity rules for company boards - MySA

    Official Inspection Station in San Antonio is one of many companies feeling the effects of the ... biotech and industrial companies as well.

  • Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in ...

    Gonzalez Convention Center in San Antonio, Texas. ‌. The poster presents ... Celcuity is a clinical-stage biotechnology company focused on ...

  • LYNPARZA® (olaparib) demonstrated clinically meaningful prolonged survival benefit ... - BioSpace

    These results were presented today at the San Antonio Breast Cancer ... Sarepta, Biotech's Regulatory Go-Getter, Signs Standout Rare Disease Deal.